Prognosis is worse. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Lymph Nodes Bile Ducts, Intrahepatic Neoplastic Cells, Circulating Tumor Cells, Cultured

Organisms1

Diseases87

Breast Neoplasms Lymphatic Metastasis Adenocarcinoma Neoplasm Invasiveness Lung Neoplasms Disease Progression Carcinoma, Squamous Cell Recurrence Liver Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Carcinoma Colorectal Neoplasms Carcinoma, Hepatocellular Brain Neoplasms Stomach Neoplasms Acute Disease Fetal Alcohol Spectrum Disorders Esophageal Neoplasms Heart Failure Myocardial Infarction Pancreatic Neoplasms Adenocarcinoma, Mucinous Melanoma Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Skin Neoplasms Chronic Disease Kidney Neoplasms Neoplasms Carcinoma, Ductal, Breast Postoperative Complications Bone Neoplasms Chromosome Aberrations Leukemia, Myeloid, Acute Lymphoma, Large B-Cell, Diffuse Cholangiocarcinoma Glioblastoma Head and Neck Neoplasms Bile Duct Neoplasms Sarcoma Carcinoma, Renal Cell Vision Disorders Carcinoma, Pancreatic Ductal Precursor Cell Lymphoblastic Leukemia-Lymphoma Uterine Cervical Neoplasms Gallbladder Neoplasms Glioma Syndrome Stroke Prostatic Neoplasms Neovascularization, Pathologic Osteosarcoma Lymphoma, Non-Hodgkin Colonic Neoplasms Carcinoma, Papillary Astrocytoma Rectal Neoplasms Mouth Neoplasms Neoplasms, Glandular and Epithelial Thyroid Neoplasms Ventricular Dysfunction, Left Neoplastic Cells, Circulating Urinary Bladder Neoplasms Remission, Spontaneous Leukemia, Lymphocytic, Chronic, B-Cell Carcinoma, Adenosquamous Genetic Predisposition to Disease Carcinoma, Signet Ring Cell Kidney Failure, Chronic Lymphoma, B-Cell Translocation, Genetic Coma Endometrial Neoplasms Pregnancy Complications, Neoplastic Gastrointestinal Neoplasms Hodgkin Disease Lymphoma Liver Cirrhosis Cerebral Hemorrhage Nasopharyngeal Neoplasms Cerebellar Neoplasms Soft Tissue Neoplasms Carcinoma, Small Cell Leukemia, Myeloid Leiomyosarcoma Central Nervous System Neoplasms

Chemicals and Drugs29

Tumor Markers, Biological Biological Markers Receptor, erbB-2 Antineoplastic Agents Ki-67 Antigen Receptors, Estrogen Tumor Suppressor Protein p53 Receptors, Progesterone DNA, Neoplasm RNA, Messenger Cyclophosphamide Vincristine Doxorubicin Antigens, Neoplasm Prednisone alpha-Fetoproteins Cisplatin MicroRNAs RNA, Neoplasm Tumor Suppressor Proteins Receptor, Epidermal Growth Factor Proto-Oncogene Proteins fms-Like Tyrosine Kinase 3 Nuclear Proteins Fluorouracil Carcinoembryonic Antigen Vascular Endothelial Growth Factor A Natriuretic Peptide, Brain Antibodies, Monoclonal

Analytical, Diagnostic and Therapeutic Techniques and Equipment91

Prognosis Survival Analysis Survival Rate Retrospective Studies Treatment Outcome Follow-Up Studies Neoplasm Staging Kaplan-Meier Estimate Disease-Free Survival Immunohistochemistry Multivariate Analysis Prospective Studies Predictive Value of Tests Risk Factors Cohort Studies Proportional Hazards Models Severity of Illness Index Combined Modality Therapy Tissue Array Analysis Risk Assessment Antineoplastic Combined Chemotherapy Protocols Neoplasm Grading Gene Expression Profiling Chi-Square Distribution Tomography, X-Ray Computed Case-Control Studies Immunoenzyme Techniques Chemotherapy, Adjuvant Reverse Transcriptase Polymerase Chain Reaction Incidence Visual Acuity Sensitivity and Specificity Questionnaires Analysis of Variance Biopsy Registries Reproducibility of Results Regression Analysis Magnetic Resonance Imaging Statistics, Nonparametric Oligonucleotide Array Sequence Analysis Fatal Outcome Logistic Models In Situ Hybridization, Fluorescence Prevalence Remission Induction Cross-Sectional Studies Longitudinal Studies Polymerase Chain Reaction Radiotherapy, Adjuvant Hospital Mortality Electrocardiography Hospitalization ROC Curve Tumor Burden Gastrectomy Life Tables Risk Palliative Care Neoadjuvant Therapy Clinical Trials as Topic Odds Ratio Real-Time Polymerase Chain Reaction Actuarial Analysis Mitotic Index Lymph Node Excision Blotting, Western Karyotyping Cause of Death DNA Mutational Analysis Stroke Volume Patient Selection Activities of Daily Living Randomized Controlled Trials as Topic Probability Hepatectomy Echocardiography Early Diagnosis Postoperative Period Epidemiologic Methods Disability Evaluation Exercise Test Treatment Failure Health Status Indicators Biopsy, Needle Statistics as Topic Positron-Emission Tomography Linear Models Sickness Impact Profile Preoperative Care Multicenter Studies as Topic

Psychiatry and Psychology5

Visual Acuity Neuropsychological Tests Cognition Disorders Depression Truth Disclosure

Phenomena and Processes30

Time Factors Gene Expression Regulation, Neoplastic Chi-Square Distribution Visual Acuity Sensitivity and Specificity Mutation Cell Proliferation Chromosome Aberrations Genes, erbB-1 Gene Amplification DNA Methylation Genotype Phenotype Drug Resistance, Neoplasm Risk Odds Ratio Apoptosis Ploidies Genes, p53 Recovery of Function Up-Regulation Stroke Volume Pregnancy Signal Transduction Probability Remission, Spontaneous Genetic Predisposition to Disease Translocation, Genetic Gene Expression Genes, erbB-2

Disciplines and Occupations3

Immunohistochemistry Outcome Assessment (Health Care)Statistics as Topic

Anthropology, Education, Sociology and Social Phenomena7

Quality of Life Health Status Survival Age Distribution Activities of Daily Living Truth Disclosure Sex Distribution

Humanities1

Quality of Life

Information Science9

Survival Rate Incidence Questionnaires Registries Fatal Outcome Prevalence Hospital Mortality Life Tables Cause of Death

Named Groups2

Infant, Newborn Survivors

Health Care62

Survival Analysis Survival Rate Retrospective Studies Treatment Outcome Follow-Up Studies Kaplan-Meier Estimate Disease-Free Survival Multivariate Analysis Prospective Studies Predictive Value of Tests Risk Factors Cohort Studies Proportional Hazards Models Severity of Illness Index Age Factors Risk Assessment Chi-Square Distribution Case-Control Studies Sex Factors Incidence Sensitivity and Specificity Questionnaires Analysis of Variance Registries Reproducibility of Results Regression Analysis Statistics, Nonparametric Comorbidity Fatal Outcome Logistic Models Prevalence Health Status Cross-Sectional Studies Longitudinal Studies Hospital Mortality Hospitalization ROC Curve Life Tables Risk Palliative Care Clinical Trials as Topic Age of Onset Odds Ratio Outcome Assessment (Health Care)Actuarial Analysis Cause of Death Age Distribution Patient Selection Activities of Daily Living Randomized Controlled Trials as Topic Probability Postoperative Period Epidemiologic Methods Treatment Failure Health Status Indicators Intensive Care Units Statistics as Topic Linear Models Sickness Impact Profile Sex Distribution Preoperative Care Multicenter Studies as Topic

Geographicals3

Japan China Italy

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prognosis Survival Analysis Survival Rate Retrospective Studies Treatment Outcome Follow-Up Studies Neoplasm Staging Kaplan-Meier Estimate Tumor Markers, Biological Disease-Free Survival Immunohistochemistry Time Factors Multivariate Analysis Breast Neoplasms Prospective Studies Predictive Value of Tests Risk Factors Lymphatic Metastasis Gene Expression Regulation, Neoplastic Cohort Studies Adenocarcinoma Proportional Hazards Models Severity of Illness Index Neoplasm Invasiveness Lung Neoplasms Age Factors Disease Progression Carcinoma, Squamous Cell Recurrence Combined Modality Therapy Liver Neoplasms Neoplasm Metastasis Neoplasm Recurrence, Local Cell Line, Tumor Tissue Array Analysis Risk Assessment Carcinoma Antineoplastic Combined Chemotherapy Protocols Neoplasm Grading Gene Expression Profiling Quality of Life Biological Markers Colorectal Neoplasms Carcinoma, Hepatocellular Brain Neoplasms Stomach Neoplasms Chi-Square Distribution Receptor, erbB-2 Acute Disease Tomography, X-Ray Computed Fetal Alcohol Spectrum Disorders Esophageal Neoplasms Heart Failure Case-Control Studies Immunoenzyme Techniques Antineoplastic Agents Myocardial Infarction Pancreatic Neoplasms Ki-67 Antigen Sex Factors Chemotherapy, Adjuvant Reverse Transcriptase Polymerase Chain Reaction Incidence Receptors, Estrogen Adenocarcinoma, Mucinous Visual Acuity Melanoma Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Sensitivity and Specificity Questionnaires Analysis of Variance Biopsy Tumor Suppressor Protein p53 Registries Reproducibility of Results Mutation Regression Analysis Receptors, Progesterone Magnetic Resonance Imaging Skin Neoplasms Chronic Disease DNA, Neoplasm Statistics, Nonparametric Kidney Neoplasms Japan Infant, Newborn Oligonucleotide Array Sequence Analysis RNA, Messenger Comorbidity Lymph Nodes Fatal Outcome Logistic Models Neoplasms Cell Proliferation Carcinoma, Ductal, Breast In Situ Hybridization, Fluorescence Postoperative Complications Prevalence Bone Neoplasms

No FAQ available that match "prognosis is worse"